As of Jul 24
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Starpharma Holdings Ltd have a median target of 6.26, with a high estimate of 7.62 and a low estimate of 4.90. The median estimate represents a +1.96% increase from the last price of 6.14.
The current consensus among 3 polled investment analysts is to Buy stock in Starpharma Holdings Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.